Rounds
Samplix
Samplix develops microfluidic technology for high-throughput single-cell functional analysis and antibody discovery.
Samplix is a biotech & life sciences company based in Birkerød, DK, founded in 2013. It has raised $27.88 million in disclosed funding. Its latest round was a Seed of €25 million in October 2026.
Overview
Samplix develops microfluidics technology designed for high-throughput single-cell analysis [1]. Founded in 2013, the company produces the Xdrop platform, which enables researchers to encapsulate individual cells in stable, uniform double-emulsion droplets [0, 1]. This droplet-based method functions as an isolated microreactor, allowing scientists to perform functional assays—such as secretion analysis, cell-cell interaction studies, and cytotoxicity screenings—using standard flow cytometers and cell sorters already present in laboratory infrastructure [0, 1]. By allowing researchers to link functional behavior to specific cells without requiring specialized proprietary detection systems, the platform aims to democratize access to high-throughput screening [1]. The company's technology supports applications across genomics, molecular biology, and immunotherapy research [1, 2]. Samplix, which is at the seed stage and has raised $27.875 million [Registry], recently secured a €25 million first closing of a financing round in October 2026 to accelerate commercial expansion for its antibody discovery platform [1].
single-cell analysismicrofluidicsantibody discoveryimmunotherapybiotechnologyflow cytometrycell biology
Funding
Total disclosed: $27.9M across 1 round. Computed only from sourced rounds.
Investors
In the news
Questions and answers
What does Samplix do?
Samplix develops microfluidic technology for high-throughput single-cell functional analysis and antibody discovery.
How much has Samplix raised?
Samplix has raised $27.88 million in disclosed funding across 1 round tracked by OSH.
Who has invested in Samplix?
Investors in Samplix include WLanholding GmbH.
When and where was Samplix founded?
Samplix was founded in 2013 and is based in Birkerød, DK.
Timeline
Founded
Sources
- 1.Danish BioTech Samplix secures €25 million in first close of financing round to scale antibody discovery — EU-Startups, Oct 28, 2026
- 2.Samplix · Official
- 3.Samplix · Official
- 4.Samplix · Official
- 5.Samplix · Official